NCT06552442View on ClinicalTrials.gov

Intracoronary Administration of Glucocorticoids as a Treatment Method for No-Glucocorticoid Treatment for No-Reflow in STEMI

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 5, 2020

Primary Completion Date

January 1, 2024

Study Completion Date

June 1, 2024

Conditions

Ischemia-reperfusion InjuryNo-reflow

Interventions

DRUG

Methylprednisolone

High-dose intracoronary glucocorticoid methylprednisolone to abrogate no-reflow: a unique study for restoration of infarct-related artery patency and reduction of ischemia-reperfusion injury

Trial Locations (1)

03038

Amosov National Institute of cardiovascular surgery, Kyiv

All Listed Sponsors

lead

Amosov National Institute of Cardiovascular Surgery

OTHER

NCT06552442 - Intracoronary Administration of Glucocorticoids as a Treatment Method for No-Glucocorticoid Treatment for No-Reflow in STEMI | Biotech Hunter | Biotech Hunter